◆英語タイトル:Riot Blockchain Inc (RIOT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010921
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Riot Blockchain Inc (Riot Blockchain), formerly known as Bioptix Inc, is an in-vitro diagnostic company focusing on development of blood-based tests in the diagnosis and treatment of acute appendicitis (AA) in children adolescent and young adult patients. Its product portfolio comprises APPY1 System which consists of a small fluorometer and consumable test products. APPYReader instrument is the fluorometer used in the system, while the test products include APPY1 Test, APPYReader QC Cassette, and APPY1 Controls. The system helps physicians to identify low disease risk for adolescent and children patients. The APPY1 System has received the CE marking in Europe. Riot Blockchain is headquartered in Castle Rock, Colorado, the US.
Riot Blockchain Inc (RIOT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Riot Blockchain Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Riot Blockchain Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Riot Blockchain Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Riot Blockchain Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Riot Blockchain Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Riot Blockchain Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Bioptix Raises USD2.3 Million in Venture Financing 10
BiOptix Diagnostics Raises Additional USD0.8 Million Financing 11
BiOptix Diagnostics Raises Additional USD0.6 Million in Financing Round 12
BiOptix Diagnostics Raises USD1 Million in Financing Round 13
Bioptix Diagnostics Raises USD1.5 Million in Venture Financing 14
Bioptix Raises USD1.4 Million in Venture Financing 15
Bioptix Diagnostics Raises US$6 Million In Venture Financing 16
Bioptix Diagnostics Raises US$0.04 Million In Venture Financing 17
Bioptix Diagnostics Raises US$9 Million In Series B Financing 18
Bioptix Diagnostics Raises US$4.5 Million In Venture Financing 19
Partnerships 20
BiOptix Enters into Agreement with XTAL BioStructures 20
Equity Offering 21
Venaxis Files Registration Statement to Raise USD50 Million in Public Offering of Shares 21
Venaxis Completes Public Offering Of Shares For US$20 Million 22
Venaxis Completes Public Offering Of Shares For US$14 Million 23
AspenBio Pharma Completes Underwriters’ Exercise Of Over-Allotment Option For US$5 Million 24
AspenBio Pharma Completes Public Offering Of Shares For US$12 Million 25
AspenBio Pharma Completes Private Placement Of Common Stock For US$1.6 Million 26
Acquisition 27
Venaxis Acquires BiOptix 27
Riot Blockchain Inc – Key Competitors 28
Riot Blockchain Inc – Key Employees 29
Riot Blockchain Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Corporate Communications 31
Apr 10, 2017: Bioptix Announces Executive Leadership Change 31
Jan 20, 2017: Bioptix Announces Streamlining of Workforce 32
Jan 06, 2017: Bioptix Reports Board of Director Changes 33
Legal and Regulatory 34
Dec 08, 2016: Venaxis Reports Name Change to Bioptix and NASDAQ Ticker Symbol Change to BIOP from APPY 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Riot Blockchain Inc, Medical Equipment, Key Facts, 2015 2
Riot Blockchain Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Riot Blockchain Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Riot Blockchain Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Riot Blockchain Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Riot Blockchain Inc, Deals By Market, 2011 to YTD 2017 8
Riot Blockchain Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Bioptix Raises USD2.3 Million in Venture Financing 10
BiOptix Diagnostics Raises Additional USD0.8 Million Financing 11
BiOptix Diagnostics Raises Additional USD0.6 Million in Financing Round 12
BiOptix Diagnostics Raises USD1 Million in Financing Round 13
Bioptix Diagnostics Raises USD1.5 Million in Venture Financing 14
Bioptix Raises USD1.4 Million in Venture Financing 15
Bioptix Diagnostics Raises US$6 Million In Venture Financing 16
Bioptix Diagnostics Raises US$0.04 Million In Venture Financing 17
Bioptix Diagnostics Raises US$9 Million In Series B Financing 18
Bioptix Diagnostics Raises US$4.5 Million In Venture Financing 19
BiOptix Enters into Agreement with XTAL BioStructures 20
Venaxis Files Registration Statement to Raise USD50 Million in Public Offering of Shares 21
Venaxis Completes Public Offering Of Shares For US$20 Million 22
Venaxis Completes Public Offering Of Shares For US$14 Million 23
AspenBio Pharma Completes Underwriters' Exercise Of Over-Allotment Option For US$5 Million 24
AspenBio Pharma Completes Public Offering Of Shares For US$12 Million 25
AspenBio Pharma Completes Private Placement Of Common Stock For US$1.6 Million 26
Venaxis Acquires BiOptix 27
Riot Blockchain Inc, Key Competitors 28
Riot Blockchain Inc, Key Employees 29